loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.favorites
.
.
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.
favorites
.
.